Albert M. Maguire
Publications by Year
Research Areas
Retinal Development and Disorders, Retinal Diseases and Treatments, Virus-based gene therapy research, Retinal and Optic Conditions, Glaucoma and retinal disorders
Most-Cited Works
- → Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis(2008)2,126 cited
- → Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial(2017)1,826 cited
- → Gene therapy restores vision in a canine model of childhood blindness(2001)1,189 cited
- → Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial(2009)852 cited
- → Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration(2009)551 cited
- → Long-Term Restoration of Rod and Cone Vision by Single Dose rAAV-Mediated Gene Transfer to the Retina in a Canine Model of Childhood Blindness(2005)473 cited
- → Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial(2016)450 cited
- Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.(2003)
- → AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness(2012)387 cited
- → Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy(2019)374 cited